XERIS PHARMACEUTICALS INC — Form D
XERIS PHARMACEUTICALS INC of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-11. The offering totals $50.0M, of which $41.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-01-11
- Form: D
- Accession: 0001346302-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $41.0M
- Remaining: $9.0M
- Investors: 47
- Date of first sale: 2015-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-254861
Issuer
- Name: XERIS PHARMACEUTICALS INC
- CIK: 0001346302
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3925 WEST BRAKER LANE, AUSTIN, TX, 78759
- Phone: 512-534-8340
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Phillip Johnson | Executive Officer | Austin, TX |
| Yash Sabharwal | Executive Officer | Austin, TX |
| Jonathan Rigby | Director | Mississauga, A6 |
| TIMOTHY SULLIVAN | Director | Austin, TX |
| Navneet Puri | Director | Bridgewater, NJ |
| Douglas Baum | Director | Austin, TX |
| Douglas Baum | Executive Officer | Austin, TX |
| Cary McNair | Director | Houston, TX |
| John Shannon | Executive Officer | Burnsville, MN |
| Paul Edick | Director | Chicago, IL |
| Paul Edick | Executive Officer | Chicago, IL |
| Robert Faulker | Director | Chicago, IL |
| Brad Huckabee | Executive Officer | Chicago, IL |
| Poul Strange | Executive Officer | Austin, TX |
| Steven Prestrelski | Director | Austin, TX |
| Steven Prestrelski | Executive Officer | Austin, TX |
| John Kinzell | Director | Austin, TX |
| John Kinzell | Executive Officer | Austin, TX |
| Shane Brisbin | Director | Austin, TX |
| Doug Baum | Director | Austin, TX |
| John Kinzel | Director | Austin, TX |
| John Kinzel | Executive Officer | Austin, TX |
| Mark Saliman | Executive Officer | Austin, TX |
Other filings by this issuer (9)
More